“…Other frequent CNVs include chromosome 9p deletion, which contains tumor suppressor genes Cyclin-Dependent Kinase Inhibitor 2A and 2B (CDKN2A/B) [15], and loss of chromosomes 2p, 4p, 6q, 7p, 9p, 10q, 11p, 14q, 17q, and 18q [29][30][31][32][33][34][35][36][37]. Chromosome 2p loss is associated with choroid meningiomas, while anaplastic meningiomas demonstrate chromosome 1p, 6p, 14, and 22q losses [15]. CDKN2A/B mutations are associated with recurrent and aggressive tumors [38,39], multiple copies of chromosome 5 are found in angiomatous meningiomas [36], gains in chromosome 22q are more often found in skull base regions, while losses at 1p, 8p, 14q and 22q correlate with non-skull base locations [33,40].…”